Cargando…
Development of a Small D-Enantiomeric Alzheimer’s Amyloid-β Binding Peptide Ligand for Future In Vivo Imaging Applications
Alzheimer’s disease (AD) is a devastating disease affecting predominantly the aging population. One of the characteristic pathological hallmarks of AD are neuritic plaques, consisting of amyloid-β peptide (Aβ). While there has been some advancement in diagnostic classification of AD patients accordi...
Autores principales: | Funke, Susanne Aileen, Bartnik, Dirk, Glück, Julian Marius, Piorkowska, Kasia, Wiesehan, Katja, Weber, Urs, Gulyas, Balazs, Halldin, Christer, Pfeifer, Andrea, Spenger, Christian, Muhs, Andreas, Willbold, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404088/ https://www.ncbi.nlm.nih.gov/pubmed/22848501 http://dx.doi.org/10.1371/journal.pone.0041457 |
Ejemplares similares
-
Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
por: Dammers, Christina, et al.
Publicado: (2016) -
Peptides for Therapy and Diagnosis of Alzheimer’s Disease
por: Funke, Susanne Aileen, et al.
Publicado: (2012) -
The D-amino acid peptide D3 reduces amyloid fibril boosted HIV-1 infectivity
por: Widera, Marek, et al.
Publicado: (2014) -
Inhibition of Polyglutamine Misfolding with D-Enantiomeric Peptides Identified by Mirror Image Phage Display Selection
por: Kolkwitz, Pauline Elisabeth, et al.
Publicado: (2022) -
Stabilization of Monomeric Tau Protein by All D-Enantiomeric Peptide Ligands as Therapeutic Strategy for Alzheimer’s Disease and Other Tauopathies
por: Altendorf, Tim, et al.
Publicado: (2023)